Saturday 17 October 2026
Export AZTA’s income statement to Excel — free account
Azenta, Inc.
AZTA Healthcare Medical Instruments & Supplies
Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS grew 104.4% and free cash flow fell 134.7%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.
34.09
2.43
−6.65%
Follow AZTA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 6 | 7 |
+8 more TTM periods Free account |
| (7.72%) | (10.65%) | (3.51%) | (3.19%) | ||
| (6.31%) | (8.79%) | (2.93%) | (2.68%) | ||
ROIC |
(9.27%) | (9.23%) | (1.22%) | (1.21%) | |
Return on Tangible Assets |
(21.15%) | (27.02%) | (9.06%) | (8.93%) | |
Average Days of Receivables |
88.91 | 84.54 | 92.11 | 93.37 | |
Free Cash Flow per Share |
0.22 | 0.65 | 0.67 | 0.84 | |
Free Cash Flow |
9.88 | 30.05 | 30.93 | 38.32 | |
Capital Expenditures |
(28.09) | (32.29) | (32.30) | (33.86) | |
| Other line items | |||||
Cash ROIC |
0.54% | 1.55% | 1.45% | 1.85% | |
Accounts Receivable Turnover |
4.48 | 4.15 | 3.90 | 3.60 | |
Accounts Payable Turnover |
8.88 | 9.19 | 9.36 | 9.11 | |
Inventory Turnover |
4.30 | 4.10 | 4.04 | 4.42 | |
Average Days of Payables |
41.85 | 36.42 | 42.90 | 42.56 | |
Days of Inventory on Hand |
84.05 | 86.30 | 91.24 | 84.56 | |
Tax Rate |
(0.26) | (0.26) | (5.39) | (4.42) | |
Research and Development Expense of Revenue |
5.82% | 5.75% | 5.46% | 5.12% | |
Selling, General and Administrative Expense of Revenue |
41.93% | 41.96% | 42.38% | 44.05% | |
Share Based Compensation of Revenue |
3.16% | 2.99% | 3.33% | 3.52% | |
Operating CF/Net income |
(0.31) | (0.36) | (1.05) | (1.29) | |
Depreciation/Fixed assets |
1.18 | 1.19 | 0.36 | 0.39 | |
Capex/Depreciation |
(0.14) | (0.16) | (0.58) | (0.57) | |
Revenue per Share |
13.55 | 12.95 | 12.96 | 12.98 | |
Operating CF per Share |
0.84 | 1.35 | 1.38 | 1.58 | |
Capex per Share |
(0.62) | (0.70) | (0.70) | (0.74) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.06 |
Columns are period end dates